<DOC>
	<DOCNO>NCT01591304</DOCNO>
	<brief_summary>This study evaluate effectiveness Ultherapy treatment facial acne .</brief_summary>
	<brief_title>Feasibility Study : Ulthera® System Treatment Moderate Severe Facial Acne</brief_title>
	<detailed_description>Study subject assign one two treatment group . Both treatment group receive treatment center forehead/temples , medial cheek , chin region use 1.5mm 1.0mm transducer . - For Group A , 1.5mm 1.0mm transducer use 0.25J energy set 0.20J energy setting , respectively . - For Group B , 1.5mm 1.0mm transducer use 0.18J energy set 0.15J energy setting , respectively . Subjects receive 3 Ultherapy treatment administer 2 week apart . Subjects required return follow-up assessment 14 , 30 , 60 , 90 180 day follow third Ultherapy treatment . Pre- post-treatment photo take . In addition , pre- post-treatment lesion count sebum measurement obtain .</detailed_description>
	<mesh_term>Facies</mesh_term>
	<criteria>Male female , age 18 year old . Subject good health . Presence clinicallyevident facial acne moderate severe severity least 20 inflammatory lesion 20100 noninflammatory lesion . Presence &gt; 2 nodular lesion area treat . Presence cysts area treat . Presence active systemic local skin disease may affect wound healing . Use alcoholbased topical solution `` exfoliate '' agent within 1 week prior study participation . History frequent herpes simplex infection face clinical evidence active herpes simplex infection . History keloid scar formation . Significant scar area treat . Significant open facial wound lesion . Presence metal stent implant facial area treat .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Ulthera® System</keyword>
	<keyword>Ultherapy™ Treatment</keyword>
	<keyword>Ulthera , Inc .</keyword>
</DOC>